Skip to Main Content

Paper Details

Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine.
Nat Med
25
2023
Diabetes, diabetes, gestational, monogenic, people, type 1, type 2
Author NameAffiliation
Anna R KahkoskaUniversity of North Carolina at Chapel Hill
Rachel G MillerUniversity of Pittsburgh
Dana DabeleaUniversity of Colorado Anschutz Medical Campus
Aaron J DeutschCenter for Genomic Medicine, Massachusetts General Hospital
Aaron J DeutschHarvard Medical School
Aaron J DeutschBroad Institute
Mark O GoodarziCedars-Sinai Medical Center
Mark O GoodarziCedars-Sinai Medical Center
Torben HansenNovo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen
Sarah Alice LongCenter for Translational Immunology, Benaroya Research Institute
William L LoweNorthwestern University Feinberg School of Medicine
Suna Onengut-GumuscuCenter for Public Health Genomics, University of Virginia
James S PankowSchool of Public Health, University of Minnesota
Camille E PoweMassachusetts General Hospital
Camille E PoweMassachusetts General Hospital and Harvard Medical School
Camille E PoweHarvard Medical School
Camille E PoweBroad Institute
Elizabeth SelvinWelch Center for Prevention, and Clinical Research, Johns Hopkins Bloomberg School of Public Health
Elizabeth SelvinJohns Hopkins Bloomberg School of Public Health
Wayne Huey-Herng SheuInstitute of Molecular and Genomic Medicine, National Health Research Institutes
Wayne Huey-Herng SheuTaipei Veterans General Hospital
Wayne Huey-Herng SheuTaichung Veterans General Hospital
Cate SpeakeCenter for Interventional Immunology, Benaroya Research Institute
Ingvild AukrustMohn Center for Diabetes Precision Medicine, University of Bergen
Ingvild AukrustHaukeland University Hospital
Kristin A MaloneyUniversity of Maryland School of Medicine
Kristin A MaloneyUniversity of Maryland School of Medicine
Janne MolnesMohn Center for Diabetes Precision Medicine, University of Bergen
Janne MolnesHaukeland University Hospital
Pål R NjølstadMohn Center for Diabetes Precision Medicine, University of Bergen
Pål R NjølstadChildren and Youth Clinic, Haukeland University Hospital
Jose C FlorezMassachusetts General Hospital
Jose C FlorezHarvard Medical School
Jose C FlorezBroad Institute
Jose C FlorezCenter for Genomic Medicine, Massachusetts General Hospital
Anna L GloynStanford School of Medicine, Stanford University
Anna L GloynStanford School of Medicine, Stanford University
Anna L GloynStanford Diabetes Research Center, Stanford School of Medicine, Stanford University
Andrew T HattersleyUniversity of Exeter Medical School
Andrew T HattersleyRoyal Devon University Healthcare NHS Foundation Trust
Marie-France HivertMassachusetts General Hospital
Marie-France HivertUniversite de Sherbrooke
Marie-France HivertHarvard Medical School, Harvard Pilgrim Health Care Institute
Soo Heon KwakSeoul National University College of Medicine, Seoul National University Hospital
Lori M LaffelJoslin Diabetes Center, Harvard Medical School
Ruth J F LoosNovo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen
Ruth J F LoosCharles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai
Ronald C W MaChinese University of Hong Kong
Ronald C W MaHong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong
Ronald C W MaLi Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong
  • 1 - 50

Datasets